Yoshikazu Inoue Selected Research

Idiopathic Interstitial Pneumonias

1/2022	Anti-Myxovirus Resistance Protein-1 Immunoglobulin A Autoantibody in Idiopathic Pulmonary Fibrosis.
1/2021	Prognostic significance of serum cytokines during acute exacerbation of idiopathic interstitial pneumonias treated with thrombomodulin.
1/2021	Hemosiderin-Laden Macrophages in Bronchoalveolar Lavage: Predictive Role for Acute Exacerbation of Idiopathic Interstitial Pneumonias.
8/2020	Seroradiologic prognostic evaluation of acute exacerbation in patients with idiopathic interstitial pneumonia: a retrospective observational study.
4/2020	Acute exacerbation of idiopathic interstitial pneumonias related to chemotherapy for lung cancer: nationwide surveillance in Japan.
1/2020	Nintedanib in patients with progressive fibrosing interstitial lung diseases-subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial.
1/2020	Efficacy of recombinant thrombomodulin for poor prognostic cases of acute exacerbation in idiopathic interstitial pneumonia: secondary analysis of the SETUP trial.
1/2019	Recombinant thrombomodulin for acute exacerbation in idiopathic interstitial pneumonias.
1/2018	Corticosteroids in acute exacerbations of idiopathic interstitial pneumonias: Time to debate - Reply.
10/2017	High-dose prednisolone after intravenous methylprednisolone improves prognosis of acute exacerbation in idiopathic interstitial pneumonias.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoshikazu Inoue Research Topics

Disease

29	Idiopathic Pulmonary Fibrosis 02/2022 - 09/2002
27	Pulmonary Alveolar Proteinosis 11/2021 - 12/2004
23	Lymphangioleiomyomatosis (Lymphangiomyomatosis) 01/2022 - 09/2002
18	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 12/2007
18	Lung Diseases (Lung Disease) 11/2021 - 08/2007
15	Idiopathic Interstitial Pneumonias 01/2022 - 04/2007
11	Disease Progression 10/2020 - 05/2014
10	Infections 05/2022 - 02/2004
8	Dyspnea (Shortness of Breath) 01/2021 - 09/2005
7	Neoplasms (Cancer) 03/2022 - 08/2003
7	Fibrosis (Cirrhosis) 01/2022 - 02/2004
7	Tuberculosis (Tuberculoses) 01/2021 - 07/2004
7	Pneumonia (Pneumonitis) 01/2021 - 06/2007
6	Bronchiectasis 11/2021 - 04/2009
5	Connective Tissue Diseases (Connective Tissue Disease) 01/2022 - 09/2015
5	Sarcoidosis (Schaumann Disease) 01/2022 - 02/2008
5	Chronic Obstructive Pulmonary Disease (COPD) 12/2021 - 01/2019
5	Tuberous Sclerosis (Bourneville's Disease) 01/2019 - 09/2010
4	Lung Neoplasms (Lung Cancer) 07/2022 - 07/2018
4	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 07/2012
4	Body Weight (Weight, Body) 12/2021 - 08/2003
4	Extrinsic Allergic Alveolitis (Hypersensitivity Pneumonitis) 01/2021 - 12/2015
4	Emphysema 01/2021 - 04/2009
4	Respiratory Insufficiency (Respiratory Failure) 01/2015 - 01/2006
3	Hypoxia (Hypoxemia) 10/2020 - 04/2008
3	Extensively Drug-Resistant Tuberculosis 01/2020 - 05/2009
3	Lung Injury 11/2019 - 08/2013
2	Asthma (Bronchial Asthma) 07/2022 - 08/2020
2	Lymphadenopathy 07/2022 - 08/2013
2	Chylothorax 07/2022 - 01/2018
2	Pneumothorax 11/2021 - 11/2017
2	Exanthema (Rash) 03/2021 - 04/2020
2	Rare Diseases (Rare Disease) 10/2020 - 03/2010
2	Fever (Fevers) 04/2020 - 05/2004
2	Cough 04/2020 - 09/2005
2	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 04/2020 - 06/2002
2	Hemorrhage 01/2020 - 01/2019
2	Langerhans-Cell Histiocytosis (Histiocytosis, Langerhans Cell) 01/2020 - 09/2010
2	Diarrhea 10/2019 - 05/2014
2	Cysts 02/2019 - 08/2013
2	Cryptogenic Organizing Pneumonia 01/2017 - 08/2007
2	Breast Neoplasms (Breast Cancer) 02/2016 - 01/2003
2	Crazy paving pattern 01/2015 - 11/2014
2	Vascular Diseases (Vascular Disease) 11/2014 - 08/2007
2	Granuloma 09/2013 - 02/2008
2	Acquired Pulmonary Alveolar Proteinosis 11/2009 - 04/2008

Drug/Important Bio-Agent (IBA)

18	lipoarabinomannan (LAM)IBA 11/2021 - 09/2002
18	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2021 - 12/2004
16	AutoantibodiesIBA 01/2022 - 05/2005
15	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2021 - 08/2011
14	nintedanibIBA 01/2022 - 05/2014
14	Pharmaceutical PreparationsIBA 01/2021 - 06/2007
12	Biomarkers (Surrogate Marker)IBA 07/2022 - 01/2006
10	Sirolimus (Rapamycin)FDA Link 01/2022 - 04/2011
8	Surface-Active Agents (Surfactants)IBA 11/2021 - 02/2004
7	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 09/2013
7	Vascular Endothelial Growth Factor DIBA 02/2019 - 01/2008
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2012
5	CollagenIBA 07/2017 - 08/2007
4	Morphine (MS Contin)FDA LinkGeneric 12/2021 - 01/2017
4	Anti-Bacterial Agents (Antibiotics)IBA 03/2021 - 02/2008
4	ThrombomodulinIBA 01/2021 - 01/2019
4	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 01/2020 - 02/2014
4	AntigensIBA 01/2020 - 07/2004
4	Carbon MonoxideIBA 01/2020 - 04/2008
4	EnzymesIBA 01/2019 - 06/2002
4	Interleukin-12 (IL 12)IBA 01/2011 - 03/2005
4	VaccinesIBA 01/2011 - 03/2005
3	Rifampin (Rifampicin)FDA LinkGeneric 01/2021 - 01/2019
3	DNA (Deoxyribonucleic Acid)IBA 04/2020 - 03/2005
3	Oxygen (Dioxygen)IBA 01/2019 - 02/2014
3	pirfenidoneIBA 09/2015 - 03/2014
3	DNA VaccinesIBA 01/2011 - 02/2006
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2011 - 03/2005
2	CytokinesIBA 02/2022 - 01/2021
2	Monoclonal AntibodiesIBA 01/2022 - 09/2013
2	Immunoglobulin A (IgA)IBA 01/2022 - 01/2020
2	Bleomycin (Blenoxane)FDA LinkGeneric 01/2022 - 07/2012
2	Clarithromycin (Biaxin)FDA LinkGeneric 03/2021 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2021
2	AntibodiesIBA 01/2020 - 12/2007
2	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2020 - 02/2004
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 01/2019
2	Phosphotransferases (Kinase)IBA 10/2019 - 08/2013
2	SuspensionsIBA 01/2019 - 01/2019
2	trans-sodium crocetinate (crocetin)IBA 01/2019 - 09/2010
2	Biological ProductsIBA 01/2019 - 02/2004
2	budesonide-glycopyrrolate-formoterol fumarate drug combinationIBA 01/2019 - 01/2019
2	beta-cyclodextrin tetradecasulfate (CTDS)IBA 10/2018 - 09/2015
2	SteroidsIBA 01/2017 - 01/2006
2	B-Cell Activating FactorIBA 08/2016 - 09/2015
2	Liposomes (Liposome)IBA 05/2009 - 03/2005

Therapy/Procedure

28	Therapeutics 07/2022 - 09/2005
6	Traction 11/2021 - 04/2009
4	Drug Therapy (Chemotherapy) 07/2022 - 05/2004
2	Radiotherapy 07/2022 - 05/2022
2	Immunotherapy 01/2021 - 11/2019
2	Respiratory Therapy (Therapy, Respiratory) 01/2020 - 01/2006
2	Metered Dose Inhalers (Metered Dose Inhaler) 01/2019 - 01/2019
2	Lung Transplantation 11/2017 - 01/2016